{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:46:53Z","timestamp":1787687213707,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["1396-01-01-15726"],"award-info":[{"award-number":["1396-01-01-15726"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10067-021-05900-7","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:03:01Z","timestamp":1630515781000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0522-7186","authenticated-orcid":false,"given":"Saeedeh","family":"Shenavandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Sepaskhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadAli","family":"Nazarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"5900_CR1","unstructured":"Fredrick M (2016) Wigley MD aNAF, Ph.D. Raynaud\u2019s phenomenon. The New England J Medicine"},{"issue":"3","key":"5900_CR2","first-page":"148","volume":"125","author":"P Polito","year":"2020","unstructured":"Polito P, Zanatta E, Felicetti M, Benvenuti F, Favaro M, Cozzi F et al (2020) Skin ulcers in systemic sclerosis correlation with clinical phenotype in a monocentric cohort from the north-east of Italy. Clin Exp Rheumatol 125(3):148\u201353 (38 Suppl)","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"5900_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.2007.072686","volume":"67","author":"SI Nihtyanova","year":"2008","unstructured":"Nihtyanova SI, Brough GM, Black CM, Denton CP (2008) Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 67(1):120\u2013123","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5900_CR4","first-page":"2423","volume":"34","author":"E Hachulla","year":"2007","unstructured":"Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V et al (2007) Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol 34(12):2423\u20132430","journal-title":"J Rheumatol"},{"issue":"5","key":"5900_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaad.2006.02.004","volume":"54","author":"L Chung","year":"2006","unstructured":"Chung L, Fiorentino D (2006) A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. J Am Acad Dermatol 54(5):880\u2013882","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5900_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/ard.47.1.43","volume":"47","author":"NJ McHugh","year":"1988","unstructured":"McHugh NJ, Csuka M, Watson H, Belcher G, Amadi A, Ring EF et al (1988) Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud\u2019s phenomenon in systemic sclerosis. Ann Rheum Dis 47(1):43\u201347","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5900_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/ard.59.1.39","volume":"59","author":"M Ho","year":"2000","unstructured":"Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59(1):39\u201343","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5900_CR8","first-page":"786","volume":"28","author":"M Gardinali","year":"2001","unstructured":"Gardinali M, Pozzi MR, Bernareggi M, Montani N, Allevi E, Catena L et al (2001) Treatment of Raynaud\u2019s phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis. J Rheumatol 28(4):786\u2013794","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"5900_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/PL00007816","volume":"248","author":"KR Aoki","year":"2001","unstructured":"Aoki KR (2001) Pharmacology and immunology of botulinum toxin serotypes. J Neurol 248(Suppl 1):3\u201310","journal-title":"J Neurol"},{"issue":"3","key":"5900_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhsa.2008.11.026","volume":"34","author":"A Fregene","year":"2009","unstructured":"Fregene A, Ditmars D, Siddiqui A (2009) Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud\u2019s phenomenon. J Hand Surg Am 34(3):446\u2013452","journal-title":"J Hand Surg Am"},{"issue":"2A","key":"5900_CR11","first-page":"219","volume":"34","author":"LT Sato","year":"2009","unstructured":"Sato LT, Kayser C, Andrade LE (2009) Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port 34(2A):219\u2013227","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"5900_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","volume":"47","author":"JGL Avouac","year":"2017","unstructured":"Avouac JGL, Smith V, Toniolo E (2017) Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. Seminars in Arthritis and Rheumatism 47(1):86\u201394","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"11","key":"5900_CR13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"key":"5900_CR14","unstructured":"Ingegnoli F, Herrick AL, Schioppo T, Bartoli F, Ughi N, Pauling JD, et al (2020) Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus. Rheumatology (Oxford)."},{"key":"5900_CR15","doi-asserted-by":"crossref","unstructured":"Corrado A CG, Gaudio A, Foschino-Barbaro MP, Cantatore FP (2010) Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis. Joint Bone Spine.","DOI":"10.1016\/j.jbspin.2010.02.019"},{"issue":"1","key":"5900_CR16","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155\u2013160","journal-title":"J Rheumatol"},{"key":"5900_CR17","doi-asserted-by":"crossref","unstructured":"Smith V HAL, Ingegnoli F, Damjanov N, Angelis R D (2020) standardization of nailfold capillaroscopy for the assessment of the patients with Reynaud\u2019s phenomenon and systemic sclerosis. Autoimmunity Reviews.","DOI":"10.1016\/j.autrev.2020.102458"},{"key":"5900_CR18","unstructured":"Lautenbach G, Dobrota R, Mihai C, Distler O, Calcagni M, Maurer B (2020) Evaluation of botulinum toxin A injections for the treatment of refractory chronic digital ulcers in patients with systemic sclerosis. Clin Exp Rheumatol 38 Suppl 125(3):154\u201360s"},{"issue":"7","key":"5900_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2340\/00015555-2665","volume":"97","author":"SI Motegi","year":"2017","unstructured":"Motegi SI, Uehara A, Yamada K, Sekiguchi A, Fujiwara C, Toki S et al (2017) Efficacy of botulinum toxin B injection for Raynaud\u2019s phenomenon and digital ulcers in patients with systemic sclerosis. Acta Derm Venereol 97(7):843\u2013850","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"5900_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1346-8138.13030","volume":"43","author":"S Motegi","year":"2016","unstructured":"Motegi S, Yamada K, Toki S, Uchiyama A, Kubota Y, Nakamura T et al (2016) Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study. J Dermatol 43(1):56\u201362","journal-title":"J Dermatol"},{"issue":"9","key":"5900_CR21","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acr.22018","volume":"65","author":"T Tingey","year":"2013","unstructured":"Tingey T, Shu J, Smuczek J, Pope J (2013) Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. Arthritis Care Res (Hoboken) 65(9):1460\u20131471","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"5900_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","volume":"120","author":"FM Wigley","year":"1994","unstructured":"Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr et al (1994) Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis A multicenter, placebo-controlled, double-blind study. Ann Intern Med. 120(3):199\u2013206","journal-title":"Ann Intern Med."},{"issue":"12","key":"5900_CR23","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jhsa.2010.09.019","volume":"35","author":"MW Neumeister","year":"2010","unstructured":"Neumeister MW (2010) Botulinum toxin type A in the treatment of Raynaud\u2019s phenomenon. J Hand Surg Am 35(12):2085\u20132092","journal-title":"J Hand Surg Am"},{"key":"5900_CR24","doi-asserted-by":"crossref","unstructured":"Al-Ghamdi AS AN, Joharji H, Al-Qahtani D, Alghamdi H (2015) Botulinum toxin: non cosmetic and off-label dermatological uses. J Dermatol Dermatolog Surg.","DOI":"10.1016\/j.jdds.2014.06.002"},{"issue":"8","key":"5900_CR25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/rheumatology\/key113","volume":"57","author":"T Schioppo","year":"2018","unstructured":"Schioppo T, Orenti A, Boracchi P, De Lucia O, Murgo A, Ingegnoli F (2018) Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trial. Rheumatology (Oxford) 57(8):1408\u20131416","journal-title":"Rheumatology (Oxford)"},{"key":"5900_CR26","doi-asserted-by":"crossref","unstructured":"Valentina Cestelli AM, Marco Sebastiani, Emanuela Praino, Francesca Cannarile, Dilia Giuggioli, Clodoveo Ferri (2016) Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis. Mod Rheumatol.","DOI":"10.1080\/14397595.2016.1192761"},{"issue":"11","key":"5900_CR27","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3899\/jrheum.160592","volume":"43","author":"AC Trombetta","year":"2016","unstructured":"Trombetta AC, Pizzorni C, Ruaro B, Paolino S, Sulli A, Smith V et al (2016) Effects of longterm treatment with bosentan and iloprost on nailfold absolute capillary number, fingertip blood perfusion, and clinical status in systemic sclerosis. J Rheumatol 43(11):2033\u20132041","journal-title":"J Rheumatol"},{"issue":"3","key":"5900_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1346-8138.14140","volume":"45","author":"SI Motegi","year":"2018","unstructured":"Motegi SI, Sekiguchi A, Saito S, Ishibuchi H, Kishi C, Yasuda M et al (2018) Successful treatment of Raynaud\u2019s phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary. J Dermatol 45(3):349\u2013352","journal-title":"J Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05900-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:43:39Z","timestamp":1744191819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5900"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05900-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Human Ethics Review Committee of our University of Medical Science number: IR.SUMS.MED.REC.1398.360. Informed consent was obtained from all the participants before entering the study. There was no animal study in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}